BR0101523A - Pestivìrus, vacina, e, processos para imunizarcontra doença induzida por pestivìrus e parafabricar uma vacina para a proteção de um animalcontra um pestivìrus - Google Patents
Pestivìrus, vacina, e, processos para imunizarcontra doença induzida por pestivìrus e parafabricar uma vacina para a proteção de um animalcontra um pestivìrusInfo
- Publication number
- BR0101523A BR0101523A BR0101523A BR0101523A BR0101523A BR 0101523 A BR0101523 A BR 0101523A BR 0101523 A BR0101523 A BR 0101523A BR 0101523 A BR0101523 A BR 0101523A BR 0101523 A BR0101523 A BR 0101523A
- Authority
- BR
- Brazil
- Prior art keywords
- vaccine
- pestivirus
- pestiviruses
- manufacture
- processes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24361—Methods of inactivation or attenuation
- C12N2770/24362—Methods of inactivation or attenuation by genetic engineering
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24361—Methods of inactivation or attenuation
- C12N2770/24364—Methods of inactivation or attenuation by serial passage
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
"PESTIVìRUS, VACINA, E, PROCESSOS PARA IMUNIZARCONTRA DOENçA INDUZIDA POR PESTIVìRUS E PARAFABRICAR UMA VACINA PARA A PROTEçãO DE UM ANIMALCONTRA UM PESTIVìRUS". A presente invenção dirige-se amutantes de pestivírus atenuados, que tem uma capacidadereduzida para replicar, como demonstrado por tamanho de placapequeno. As mutações estão na região 5' não traduzida dogenoma viral. Estes vírus mutantes são utilizáveis como vacinasvivas no controle de diarréia viral bovina, doença das extremidadese febre de suínos clássica.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00201421 | 2000-04-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0101523A true BR0101523A (pt) | 2001-11-20 |
Family
ID=8171371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0101523A BR0101523A (pt) | 2000-04-21 | 2001-04-19 | Pestivìrus, vacina, e, processos para imunizarcontra doença induzida por pestivìrus e parafabricar uma vacina para a proteção de um animalcontra um pestivìrus |
Country Status (11)
Country | Link |
---|---|
US (1) | US7037508B2 (pt) |
EP (1) | EP1149901B1 (pt) |
JP (1) | JP4937460B2 (pt) |
AT (1) | ATE322541T1 (pt) |
BR (1) | BR0101523A (pt) |
CA (1) | CA2342305C (pt) |
DE (1) | DE60118456T2 (pt) |
DK (1) | DK1149901T3 (pt) |
ES (1) | ES2261329T3 (pt) |
MX (1) | MXPA01003968A (pt) |
PT (1) | PT1149901E (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004016794A1 (en) * | 2002-08-13 | 2004-02-26 | Akzo Nobel N.V. | Replicons of pestiviruses that do not express c and or e1 protein and infectious viral particles containing same, that can be used in vaccines |
JP2006071631A (ja) * | 2004-08-06 | 2006-03-16 | Bl:Kk | フラビウイルス科ペスチウイルス属ウイルスの検出法およびそのイムノクロマトグラフィーにおける使用 |
US8063195B2 (en) * | 2009-05-22 | 2011-11-22 | The United States Of America As Represented By The Secretary Of Agriculture | Mutations in a toll-like receptor motif in the NS4B of classical swine fever virus strain brescia influences virulence in swine |
US9920302B2 (en) * | 2015-08-31 | 2018-03-20 | Boehringer Ingelheim Vetmedica Gmbh | Pestivirus vaccines for congenital tremors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1071454A1 (en) * | 1998-04-24 | 2001-01-31 | Washington University | Chimeras of hepatitis c virus and bovine viral diarrhea virus |
EP0965639A1 (en) * | 1998-06-05 | 1999-12-22 | Boehringer Ingelheim Vetmedica Gmbh | Attenuated pestiviruses |
-
2001
- 2001-04-17 DK DK01201388T patent/DK1149901T3/da active
- 2001-04-17 EP EP01201388A patent/EP1149901B1/en not_active Expired - Lifetime
- 2001-04-17 AT AT01201388T patent/ATE322541T1/de not_active IP Right Cessation
- 2001-04-17 PT PT01201388T patent/PT1149901E/pt unknown
- 2001-04-17 DE DE2001618456 patent/DE60118456T2/de not_active Expired - Lifetime
- 2001-04-17 ES ES01201388T patent/ES2261329T3/es not_active Expired - Lifetime
- 2001-04-19 BR BR0101523A patent/BR0101523A/pt not_active Application Discontinuation
- 2001-04-19 US US09/839,796 patent/US7037508B2/en not_active Expired - Fee Related
- 2001-04-20 MX MXPA01003968A patent/MXPA01003968A/es active IP Right Grant
- 2001-04-20 JP JP2001122200A patent/JP4937460B2/ja not_active Expired - Fee Related
- 2001-04-20 CA CA 2342305 patent/CA2342305C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1149901A1 (en) | 2001-10-31 |
ES2261329T3 (es) | 2006-11-16 |
PT1149901E (pt) | 2006-08-31 |
ATE322541T1 (de) | 2006-04-15 |
DE60118456D1 (de) | 2006-05-18 |
JP4937460B2 (ja) | 2012-05-23 |
US20020086033A1 (en) | 2002-07-04 |
DK1149901T3 (da) | 2006-07-31 |
EP1149901B1 (en) | 2006-04-05 |
JP2002325575A (ja) | 2002-11-12 |
CA2342305A1 (en) | 2001-10-21 |
US7037508B2 (en) | 2006-05-02 |
CA2342305C (en) | 2010-11-09 |
DE60118456T2 (de) | 2006-08-24 |
MXPA01003968A (es) | 2003-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1090033T3 (da) | Partikler af HCV-kappeproteiner: Anvendelse til vaccination | |
MY146351A (en) | Compositions for treating infection in cattle and swine | |
CY1107570T1 (el) | Ανοσογονικα πολυπεπτιδια κωδικοποιουμενα απο μινιγονιδια mage και οι χρησεις τους | |
NO20073151L (no) | Fremgangsmater og sammensetninger for a behandle hepatitt C virus | |
ATE476510T1 (de) | Schweine-circovirus-impfstoff in rekombinantem pockenvirus | |
PL398576A1 (pl) | Preparaty szczepionek, preparaty farmaceutyczne, atenuowany wirus grypy, sposoby szczepienia, sposoby zapobiegania chorobie zakaznej, sposoby leczenia lub profilaktyki nowotworów, kompozycje szczepionek i kompozycje farmaceutyczne | |
DK0529584T3 (da) | Viralt agens forbundet med "Mystery Swine Disease" | |
ATE405647T1 (de) | Rekombinantes gelatin in impstoffen | |
DE60110822D1 (de) | Zubereitung zur immunisierung gegen den aids-virus | |
CY1110437T1 (el) | Χρηση παραγωγων καστανοσπερμινης για την θεραπεια της ηπατιτιδας c | |
BR9910749A (pt) | Composições e vacinas imunogênicas combinadas para meningites b e c e método de induzir uma resposta imune por administração da mesma | |
ES2074950A1 (es) | Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda. | |
BR0111366A (pt) | Vacina de poxvìrus recombinante do vìrus da sìndrome respiratória e reprodutiva de porcino (prrsv) | |
DK0588578T3 (da) | Immunogener | |
AU9215101A (en) | Vaccines containing ribavirin and methods of use thereof | |
DK1237549T3 (da) | Lipoxin A4 og dets analoger til behandling af törre öjne | |
DE69738271D1 (de) | Rotavirus-impfstoff | |
DE69730393D1 (de) | Impfstoffe-Zusammensetzungen die inaktivierte Immunogene und lebende Hühner-Anäemie-Virus enthalten | |
BR0101523A (pt) | Pestivìrus, vacina, e, processos para imunizarcontra doença induzida por pestivìrus e parafabricar uma vacina para a proteção de um animalcontra um pestivìrus | |
ATE276761T1 (de) | Vorbeugung von typ-1 diabetes und anderen nicht- polio enteroviren | |
EA200200743A1 (ru) | Рекомбинантное ослабление вируса репродуктивного и респираторного синдрома свиней (prrsv) | |
BR0108735A (pt) | Proteção in ovo contra bronquite infecciosa | |
DE69835424D1 (de) | Boviner atmungs- und darmcoronavirus als impfstoff | |
BR0208980A (pt) | Vacinas incluindo ifn do tipo i como um adjuvante e processos relacionados a esses | |
FR2809960B1 (fr) | Composition adjuvante de la reponse immunitaire comprenant la proteine fha ou un fragment de la proteine fha sous forme libre, et composition immunogene ou vaccinale contenant une telle composition adjuvante |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15V | Prolongation of time limit allowed |
Free format text: RECONHECIDO O OBSTACULO ADMINISTRATIVO E DEVOLVIDO O PRAZO DE 32 (TRINTA E DOIS) DIAS, NOS TERMOS DO ARTIGO 221 PARAGRAFO 2O DA LPI E DA RESOLUCAO 116/04. |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 24, 8O, 13, 10, 25 DA LPI |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |